Citi Maintains Buy on AbbVie, Raises Price Target to $98

Citi maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $90 to $98.

Benzinga · 11/20/2019 14:16

Citi maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $90 to $98.